In addition, deletion of Cdk2 in a Myc-overexpressing mouse model (Eμ-Myc) resulted in delayed development of B-cell lymphoma [9], suggesting that Myc-driven S phase entry is important to aberrant cell expansion. The gene discussed is MYC; the disease is B-cell non-Hodgkin lymphoma.